Angiomyolipoma
Showing 51 - 74 of 74
Lipid Metabolism, Inborn Errors, Hypercholesterolemia, Autosomal Dominant, Hyperlipidemias Trial in United States (mipomersen
Completed
- Lipid Metabolism, Inborn Errors
- +13 more
- mipomersen sodium
-
Chicago, Illinois
- +4 more
Aug 1, 2016
Hypercholesterolemia, Coronary Heart Disease Trial in United States (Mipomersen sodium, Placebo)
Completed
- Hypercholesterolemia
- Coronary Heart Disease
- Mipomersen sodium
- Placebo
-
Birmingham, Alabama
- +61 more
Aug 1, 2016
Diabetes, Type 2 Trial in Worldwide (Rosiglitazone, Sulfonylurea, Metformin)
Completed
- Diabetes Mellitus, Type 2
- Rosiglitazone
- +2 more
-
Miranda, New South Wales, Australia
- +446 more
Mar 21, 2017
Breast Cancer Trial in Worldwide (Letrozole, Anastrozole)
Completed
- Breast Cancer
-
Birmingham, Alabama
- +262 more
Mar 20, 2016
Adalimumab in Moderate to Severe Psoriasis in Spain
Completed
- Moderate-to-severe Chronic Plaque Psoriasis
- (no location specified)
Dec 1, 2015
Atypical Hemolytic Uremic Syndrome Trial in Worldwide (eculizumab)
Completed
- Atypical Hemolytic Uremic Syndrome
-
Toronto, Canada
- +12 more
Jun 30, 2015
Atypical Hemolytic Uremic Syndrome Trial in Worldwide (eculizumab)
Completed
- Atypical Hemolytic Uremic Syndrome
-
Toronto, Canada
- +12 more
Jun 30, 2015
Ovarian Cancer, Endometrial Cancer Trial in Baltimore (everolimus and letrozole)
Unknown status
- Ovarian Cancer
- Endometrial Cancer
- everolimus and letrozole
-
Baltimore, MarylandSinai Hospital of Baltimore, Inc.
May 18, 2015
Tuberous Sclerosis, Lymphangioleiomyomatosis Trial in Cincinnati (RAD001)
Completed
- Tuberous Sclerosis
- Lymphangioleiomyomatosis
-
Cincinnati, OhioCincinnati Children's Hospital Medical Center
Sep 23, 2013
Neurofibromatosis Type 1, Plexiform Neurofibroma, Neurofibromatoses Trial in Creteil (RAD001: Everolimus)
Completed
- Neurofibromatosis Type 1
- +2 more
- RAD001: Everolimus
-
Creteil, FranceHenri Mondor Hospital
Nov 13, 2014
Tuberous Sclerosis, Angiolipoma Trial in Cincinnati (everolimus (RAD001))
Completed
- Tuberous Sclerosis
- Angiolipoma
- everolimus (RAD001)
-
Cincinnati, OhioCincinnati Children's Hospital Medical Center
Sep 17, 2013
Chronic Myeloid Leukemia Trial in Worldwide (ponatinib, imatinib (Gleevec/ Glivec))
Terminated
- Chronic Myeloid Leukemia
- ponatinib
- imatinib (Gleevec/ Glivec)
-
Burbank, California
- +169 more
Nov 5, 2014
Multiple Sclerosis, Relapsing-Remitting Trial in Worldwide (Interferon beta-1a, Alemtuzumab 12 mg, Alemtuzumab 24 mg)
Completed
- Multiple Sclerosis, Relapsing-Remitting
- Interferon beta-1a
- +2 more
-
Scottsdale, Arizona
- +48 more
Jan 6, 2015
Observational Trial With Enbrel
Completed
- Rheumatoid Arthritis
-
Muenster, NRW, GermanyPfizer Investigational Site
Jul 25, 2014
Malignant PEComa (Perivascular Epithelioid Cell Tumors) Trial in Barcelona (BEZ235)
Withdrawn
- Malignant PEComa (Perivascular Epithelioid Cell Tumors)
-
Barcelona, Cataluña, SpainNovartis Investigative Site
Aug 1, 2013
Effect of Somatropin on Growth Hormone Deficient Adults
Completed
- Hypopituitarism
- +2 more
- Somatropin (rDNA origin)
- (no location specified)
Mar 25, 2014
Rheumatoid Arthritis Trial in Worldwide (Canakinumab, Placebo)
Type 2 Diabetes, Cardiovascular Disease Trial in Worldwide (Aliskiren, Placebo)
Terminated
- Type 2 Diabetes Mellitus
- Cardiovascular Disease
- Aliskiren
- Placebo
-
Birmingham, Alabama
- +777 more
Apr 1, 2014
Alzheimer Trial in Worldwide (Rivastigmine 5 cm^2, Rivastigmine 10 cm^2, Rivastigmine 15 cm^2)
Completed
- Alzheimer Disease
- Rivastigmine 5 cm^2
- +4 more
-
Birmingham, Alabama
- +144 more
Sep 17, 2012
Diabetes, Type 2 Trial in Investigative Site, Investigative Sites (Valsartan 160 mg + nateglinide 60 mg, Valsartan 160 mg +
Completed
- Diabetes Mellitus, Type 2
- Valsartan 160 mg + nateglinide 60 mg
- +3 more
-
Investigative Site, New Jersey
- +37 more
Jun 27, 2011
Lymphangioleiomyomatosis Trial in Canada, Japan, United States (Sirolimus, Placebo sirolimus)
Unknown status
- Lymphangioleiomyomatosis
- Sirolimus
- Placebo sirolimus
-
Los Angeles, California
- +12 more
Aug 27, 2009
Official Record of Patients Diagnosed With
Completed
- Leiomyomatosis
-
Bethesda, MarylandNational Heart, Lung and Blood Institute (NHLBI)
Mar 3, 2008